Clinical Trial Update: A Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating administering the FOLFIRINOX chemotherapy regimen before surgery for potentially curable pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• FOLFIRINOX

Snippet

Sponsor: Petr Kavan | Conditions: Pancreatic Cancer | Phase 2 | Status: UNKNOWN